semaglutide efficacy and Safety of Once-Weekly Versus Once-Daily Sitagliptin as Metformin Add-on in a Korean Population with Type 2 Diabetes | Diabetes Therapy We are all anxiously awaiting

Cardiovascular risk reduction is the highest-growth established indication in the GLP-1 market at 22.7% CAGR as SELECT trial outcomes transform prescribing beyond endocrinology into cardiology channels

In 2025, the company reported a modest +0.99% YoY revenue growth, but the underlying story is more interesting: Dupixent ($17.8B) remains the clear growth engine, benefiting from expanding indications like COPD and broader patient reach, while the EYLEA franchise ($7.89B) continues to be a core contributor despite facing biosimilar pressure, supported by the transition to EYLEA HD, and Libtayo ($1.45B) is steadily gaining ground in oncology, particularly in lung cancer settings

Important safety considerations include risks of pancreatitis, gallbladder problems, and dehydration from gastrointestinal side effects

June 6, 2024: Judge Marston is assigned the Ozempic MDL after Judge Pratters passing

Its an oral medication you take once or twice per day

However, everyone is different, so if you experience joint or muscle pain while taking Ozempic, you should consult your healthcare provider as soon as possible for guidance